Connect with us


Clynxx is bringing digital identity verification into e-prescribing

Avatar photo




Digital identity technology verifies prescribers and enables Clynxx to offer qualified prescribers instant and secure access to reduce wait times for patients. Health Tech World speaks to Clynxx founder and director, Tuck Muswizu


Clynxx, the UK’s official private advanced electronic prescription system, has announced the launch of a secure solution for checking medical prescribers identities in conjunction with UK based identity platform Yoti.

Clynxx has integrated Yoti’s biometric technology and merged it with the relevant regulatory information, allowing the platform to automatically onboard a prescriber and provide instant access to the system.

By combining regulatory information on approved prescribers with Yoti’s identity services, Clynxx offers prescribers instant access – reducing wait times for patients requiring urgent care.

If for any reason, a prescriber leaves their regulatory register, Clynxx revokes their access immediately. It means that pharmacies will have the assurance that all of Clynxx prescriptions have been created only by someone legally allowed to do so.

“The advantage is that then we can provide a real-time assurance to the pharmacies and other stakeholders that the prescription was created by someone who was allowed to create that prescription,” Tuck Muswizu, founder and director of Clynxx, told Health Tech World.

Clynxx claims to be one of the first to use digital identity verification in the e-prescribing space. In the NHS, digital IDs haven’t yet been adopted and in the private sector, Clynxx remains one of few electronic prescription providers.


Tuck Muswizu, Founder and Director of Clynxx

Muswizu said that he believes Clynxx’s dominance in the private sector is due to it being the “freest” system for patients. Unlike other systems which are confined to specific pharmacies, Clynxx allows users to use any pharmacy for dispensing prescriptions.

Before integrating Digital ID into its service, Clynxx would carry out manual checks that involved users booking an appointment to verify that they were regulated to hand out prescriptions. Where previously it would take upwards of two or three days to get a user set up on Clynxx’s e-prescription system, it now takes a matter of minutes, regardless of the time or day of the week.

“By using ID verification from Yoti, we no longer need to carry out manual checks and we can grant prescribers immediate instant access to our system so they can provide crucial care to their patients,” Muswizu said.

Yoti is a secure digital identity platform that delivers identity verification for businesses including the NHS, Co-op and Virgin Atlantic, plus government organisations including the Government of Jersey and Scottish Improvement Service. It is also the strategic identity partner for the Post Office. Over 10 million consumers have now downloaded the Yoti app globally, with 2 million in the UK.

Robin Tombs, CEO at Yoti, added: “We’re proud to see Yoti technology powering the UK’s official private advanced electronic prescription system, which is a win for medical providers and a big win for patients too.

Quickly verifying prescribers identity is an important step that will give pharmacies and patients further confidence that the prescription they receive is compliant. It’s another important step forward in the digital transformation of healthcare.”

Up until recent years, prescribers have used a paper-based system that involves copying, faxing or emailing a proof copy to a pharmacy before supplying the pen-signed original prescription within the next 72 hours.

With e-prescription services like Clynxx, prescribers can now instantly send a digital prescription straight to the patient without the need for an original paper prescription.

The adoption of new technology is notoriously slow in the healthcare sector, however like many digital solutions, e-prescription services have been receiving more interest as a result of the pandemic.

“Initially, we were just dealing with the early adopters; more guerrilla clinics that were trying to make their clinics efficient. Now, we are engaging more significant partners, large corporations, and significant stakeholders in the healthcare industry,” Muswizu said.

“When we were talking initially about our system, no one really saw how efficient it could make the clinic. The pandemic has educated everyone in general about the capabilities of digitising systems.

“It’s helped our business in being recognised which is great because when we were trying to sell to people, [they] had questions that seemed obvious to us. Now, these things have become obvious to everyone and everyone understands straight away what the system is able to provide and what problem it solves.”

Muswizu described Clynxx’s growth during the pandemic as “qualitative rather than quantitative”. The company is beginning to engage less with smaller practices, and instead focusing its efforts on working with a smaller number of stakeholders with greater influence, such as regulators, indemnity providers and other software system providers.

He added: “The healthcare industry is quite like the military; it is top-down. It’s almost as if you get the top, you get everyone and that is what we have managed to do now.”

Over the next 12 months, Clynxx is set to close a number of deals with the “most recognisable brands” in private healthcare. The company has also launched a project that allows patients on the system to control their own data by linking it with their mobile devices, like the Apple Watch.

Muswizu sees electronic prescription systems like Clynxx vastly reducing the time that prescribers currently spend on administration tasks and empowering patients to improve their own health outcomes.

“I think it’s going to allow prescribers to become the prescribers that they imagined when they were going to university, not the people who spend a lot of time doing paperwork.

“Patients’ quality of life and healthcare is going to improve because there’s a lot of information that patients will be able to access. We’ve got the hardware, like the iPhone, the wearable devices, and you’ve got the prescriber getting acute information, and you’ve got the patients being empowered to be responsible for their healthcare outcomes.”

By improving the healthcare outcomes of patients, Clynxx is also aiming to boost efficiency and reduce the number of claims that are made to private insurers by increasing the care that healthcare companies can provide digitally.

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Trending stories